Get access

A Strategy of Rapid Cardioversion Minimizes the Significance of Early Recurrent Atrial Tachyarrhythmias After Ablation for Atrial Fibrillation

Authors


  • Dr. Bunch reports honoraria from Boston Scientific, Biosense Webster, and St. Jude Medical for participation in speakers’ bureaus relevant to this topic. Dr. Weiss reports honoraria from Biosense Webster and Stereotaxis, Inc. for participation in speakers’ bureaus relevant to this topic. Dr. May reports participation on research grants supported by NIH, the Deseret Foundation, Novartis, and Atherotech. Other authors: No disclosures.

T. Jared Bunch, M.D., Intermountain Heart Rhythm Specialists, Intermountain Medical Center, Eccles Outpatient Care Center 5169 Cottonwood St., Suite 510, Murray, Utah, 84107. Fax: 801-507-3584; E-mail: Thomas.bunch@imail.org

Abstract

A Strategy of Rapid Cardioversion. Background: The significance of early recurrent atrial tachyarrhythmias after atrial fibrillation (AF) ablation is unclear. Atrial remodeling driven by these tachyarrhythmias can result in electrical, contractile, and structural changes that may impair long-term therapy success. Aggressive attempts to restore sinus rhythm in the temporal period of healing after ablation might improve outcomes.

Methods: A total of 1,759 AF ablations were performed at Intermountain Medical Center or LDS Hospital. A total of 455 of those were among patients requiring repeat ablations. Patients were instructed to take their pulse daily and, if greater than 100 bpm or irregular, present the following business day fasting to the clinic for evaluation and cardioversion if AF or atrial flutter (AFL) were present.

Results: Of the ablations performed, a total of 515 (29%, age: 65.6 ± 11.2 years, male: 57.9%) developed AF/AFL that required cardioverison. The majority of these arrhythmias first occurred in the initial 90 days (63.7%) postablation. During this period, 62.8% were on an antiarrhythmic drug (AAD). Only 25.1% were using an AAD at 3 months. The majority of ablations (75.6%) who experienced AF/AFL within the first 90 days after ablation were in sinus rhythm with no AAD at 1 year. Further, 48% of those with the first recurrence from 90 to 180 days were in sinus rhythm with no AAD at 1 year.

Conclusions: The time at which the first recurrence of AF/AFL occurs impacts long-term outcomes. An aggressive strategy of rapid cardioversion postablation reduces the significance of recurrent AF/AFL during the first 6 months. (J Cardiovasc Electrophysiol, Vol. 22, pp. 761-766, July 2011)

Get access to the full text of this article

Ancillary